ChipCare

About:

ChipCare develops a hand-held cell analyzer based on mobile technology.

Website: http://chipcare.ca

Twitter/X: ChipCare

Top Investors: Toronto Innovation Acceleration Partners, Maple Leaf Angels, Mindset Venture Group Ltd, University of Toronto Asset Management, EPIC Capital

Description:

ChipCare’s mission is to bring lab-based medical tests to patients, enabling every person around the world to have easy access to state-of-the-art blood tests. The envisioned product entails two components: handheld reader and disposable test slide. The revenue will mainly be generated from sales of disposable test slides (consumables). Our proprietary detection technique enables testing of multiple diseases from a single drop of blood sample, including cell counting, protein/enzyme and pathogen detection. ChipCare’s solution to this problem is an integrated point-of-care testing and monitoring system to address the current clinical challenges in both resource rich and resource limited settings. It combines patient identification, blood testing, communication, and external quality management protocol. It is also a platform system that can be used to test different diseases from a single drop of blood.